Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABT

Abbott Laboratories

Dec 01 • 04:00PM ET

104.88

Dollar change +0.59
Percentage change 0.57	%

Healthcare • Medical Devices • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	35.64	EPS (ttm)	2.94	Insider Own	0.70%	Shs Outstand	1.74B	Perf Week	1.95%
Market Cap	182.08B	Forward P/E	22.69	EPS next Y	4.62	Insider Trans	-0.90%	Shs Float	1.72B	Perf Month	10.39%
Income	5.14B	PEG	-	EPS next Q	1.19	Inst Own	75.87%	Short Float / Ratio	0.70% / 2.07	Perf Quarter	1.97%
Sales	39.96B	P/S	4.56	EPS this Y	-16.91%	Inst Trans	0.27%	Short Interest	12.08M	Perf Half Y	0.65%
Book/sh	21.59	P/B	4.86	EPS next Y	4.20%	ROA	7.10%	Target Price	115.37	Perf Year	-2.51%
Cash/sh	4.06	P/C	25.84	EPS next 5Y	-2.00%	ROE	14.06%	52W Range	89.67 - 115.83	Perf YTD	-4.47%
Dividend	1.99	P/FCF	40.53	EPS past 5Y	71.02%	ROI	9.90%	52W High	-9.45%	Beta	0.70
Dividend %	1.90%	Quick Ratio	1.23	Sales past 5Y	10.05%	Gross Margin	49.44%	52W Low	16.96%	ATR	1.72
Employees	115000	Current Ratio	1.74	Sales Q/Q	-2.56%	Oper. Margin	15.09%	RSI (14)	73.37	Volatility	1.30% 1.63%
Optionable	Yes	Debt/Eq	0.41	EPS Q/Q	1.02%	Profit Margin	12.87%	Rel Volume	0.80	Prev Close	104.29
Shortable	Yes	LT Debt/Eq	0.39	Earnings	Oct 18 BMO	Payout	49.05%	Avg Volume	5.84M	Price	104.88
Recom	1.78	SMA20	6.16%	SMA50	8.55%	SMA200	1.90%	Volume	4,656,295	Change	0.57%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-21-23	Upgrade	Wolfe Research	Underperform → Peer Perform
May-30-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$112
Apr-20-23	Reiterated	Wolfe Research	Underperform	$107 → $103
Apr-20-23	Reiterated	UBS	Buy	$117 → $130
Apr-20-23	Reiterated	Raymond James	Outperform	$116 → $123
Apr-20-23	Reiterated	JP Morgan	Overweight	$118 → $122
Apr-20-23	Reiterated	Bernstein	Outperform	$132 → $133
Apr-20-23	Reiterated	Barclays	Overweight	$125 → $127
Mar-29-23	Initiated	UBS	Buy	$117
Oct-26-22	Initiated	Mizuho	Neutral	$105
Oct-18-22	Initiated	Barclays	Overweight	$118
Oct-12-22	Initiated	Jefferies	Hold	$110
Jul-06-22	Initiated	Wolfe Research	Underperform	$95
Mar-02-22	Resumed	BofA Securities	Buy	$140
Jan-27-22	Reiterated	UBS	Buy	$138 → $142
Jan-27-22	Reiterated	Raymond James	Outperform	$150 → $143
Jan-27-22	Reiterated	Morgan Stanley	Overweight	$157 → $151
Jan-27-22	Reiterated	Credit Suisse	Outperform	$138 → $139
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$146
Oct-27-21	Upgrade	Atlantic Equities	Neutral → Overweight	$144

Show Previous Ratings

Nov-30-23 05:50PM	Abbott (ABT) Rises Higher Than Market: Key Facts (Zacks)
08:15AM	AbbVie Should Consider a Dividend Cut -- Here's Why (Motley Fool)
Nov-29-23 09:30AM	Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy? (Zacks)
Nov-28-23 09:00AM	Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-27-23 12:43PM	Here's Why Investors Should Retain Abbott (ABT) Stock Now (Zacks)
06:51AM	Loading…
Nov-26-23 06:51AM	15 Best Drug Stocks To Invest In (Insider Monkey)
05:56AM	12 Best Medical Technology Stocks To Buy Now (Insider Monkey)
Nov-22-23 12:15PM	20 Healthiest States in the US in 2023 (Insider Monkey)
09:10AM	Abbott (ABT) Benefits From Innovation Amid FX Headwinds (Zacks)
Nov-21-23 06:53AM	Abbott Laboratories (ABT) Declined on Concerns of New Diabetes Drug (Insider Monkey)
06:02AM	Navigating Market Uncertainty: Intrinsic Value of Abbott Laboratories (GuruFocus.com)
Nov-20-23 06:52AM	20 Most Valuable Healthcare Companies in the World (Insider Monkey)
06:03AM	Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How. (Motley Fool)
Nov-19-23 02:05PM	Ray Dalios Latest 13F Portfolio: Top 15 Stocks (Insider Monkey)
Nov-17-23 11:30AM	Abbott (ABT) Up 5.1% Since Last Earnings Report: Can It Continue? (Zacks)
10:07AM	Loading…
10:07AM	Is DexCom the Next Big Growth Stock? (Motley Fool)
08:45AM	Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029 (PR Newswire)
Nov-16-23 11:14AM	Doctors, FDA Fight Over Giving Probiotics to Premature Babies (The Wall Street Journal)
09:00AM	The Rift Over Giving Probiotics to the Tiniest Patients (The Wall Street Journal)
Nov-15-23 09:30AM	Abbott (ABT) Just Overtook the 50-Day Moving Average (Zacks)
09:00AM	Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-13-23 09:57PM	12 Best Low Risk Stocks to Buy in 2023 (Insider Monkey)
09:00AM	Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3 Heart Pump (PR Newswire)
Nov-09-23 06:00AM	2 No-Brainer Stocks to Buy for Forever Dividend Growth (Motley Fool)
04:06AM	11 Best S&P 500 Stocks To Buy According to Ray Dalios Bridgewater Associates (Insider Monkey)
03:49AM	Top 20 Drug Companies in the US by Revenue (Insider Monkey)
Nov-08-23 12:30PM	Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes (ACCESSWIRE)
09:37AM	2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity (Motley Fool)
Nov-07-23 06:02AM	Beyond Market Price: Uncovering Abbott Laboratories's Intrinsic Value (GuruFocus.com)
Nov-03-23 12:27PM	Inari Medical (NARI) Q3 Earnings and Revenues Beat Estimates (Zacks)
12:22PM	Loading…
12:22PM	AMN Healthcare (AMN) Q3 Earnings and Revenues Beat Estimates (Zacks)
09:35AM	Cardinal Health (CAH) Beats on Q1 Earnings, Ups '24 EPS View (Zacks)
09:34AM	Stryker (SYK) Q3 Earnings Beat on Strong Segmental Result (Zacks)
09:00AM	Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know (Zacks)
08:59AM	Penumbra (PEN) Q3 Earnings Top Estimates, Margins Increase (Zacks)
Nov-02-23 12:45PM	Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology (ACCESSWIRE)
12:25PM	Avanos (AVNS) Q3 Earnings Top Estimates, Margins Contract (Zacks)
12:22PM	QuidelOrtho (QDEL) Q3 Earnings Top Estimates, Margins Down (Zacks)
12:16PM	Nevro (NVRO) Q3 Earnings Top Estimates, FY23 Revenue View Up (Zacks)
11:03AM	Exact Sciences (EXAS) Q3 Earnings Beat, Gross Margin Rises (Zacks)
10:56AM	Baxter (BAX) Beats on Q3 Earnings, Divests BioPharma Business (Zacks)
10:54AM	DENTSPLY SIRONA (XRAY) Beats on Q3 Earnings, Lowers '23 Guidance (Zacks)
10:34AM	Glaukos (GKOS) Q3 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
10:32AM	McKesson (MCK) Beats on Q2 Earnings, Raises '23 EPS View (Zacks)
10:15AM	1 Stock Down 15% This Year to Buy and Hold Forever (Motley Fool)
09:00AM	Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV (PR Newswire)
01:21AM	The Abbott Laboratories (ABT) Company: A Short SWOT Analysis (GuruFocus.com)
Nov-01-23 01:00PM	Abbott and Damar Hamlin Team Up To Build Heart Health Community With New Heartmates Program (ACCESSWIRE)
11:07AM	CVS Health (CVS) Q3 Earnings Surpass Estimates, Margins Up (Zacks)
08:28AM	Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology (PR Newswire)
Oct-31-23 11:35AM	PacBio (PACB) Tops on Q3 Earnings, Raises FY23 Revenue View (Zacks)
11:07AM	Ecolab (ECL) Q3 Earnings Surpass Estimates, Margins Rise (Zacks)
08:00AM	Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program (PR Newswire)
07:57AM	Ozempic, Wegovy, and other weight loss drugs real business impact (Yahoo Finance)
07:37AM	GE HealthCare beats quarterly profit estimates on imaging device demand (Reuters)
Oct-30-23 03:15PM	Tackling Student Loans and Saving - Together (ACCESSWIRE)
02:11PM	Top Stock Reports for JPMorgan Chase, Home Depot & Salesforce (Zacks)
12:24PM	Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top (Zacks)
11:55AM	Revvity (RVTY) Misses on Q3 Earnings, Lowers '23 EPS View (Zacks)
Oct-27-23 11:35AM	Integer Holdings (ITGR) Q3 Earnings Top Estimates, FY23 View Up (Zacks)
11:16AM	Merit Medical (MMSI) Q3 Earnings Top Estimates, FY23 View Revised (Zacks)
07:30AM	DexCom (DXCM) Beats on Q3 Earnings, Raises Sales Outlook (Zacks)
Oct-26-23 06:00PM	Ninety-One Percent of Young Adults With Student Loans Say Financial Stress Is Impacting Their Wellness (ACCESSWIRE)
03:09PM	FDA warns about giving probiotics to preterm babies after infant death, other injuries (Associated Press Finance)
11:26AM	UPDATE 4-Abbott to cease sale of infant probiotic products after FDA warning (Reuters)
11:16AM	FDA issues warning letter to Abbott for probiotic products for infants (Reuters)
10:08AM	CONMED (CNMD) Beats on Q3 Earnings, Ups '23 EPS View (Zacks)
09:00AM	Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem (PR Newswire)
Oct-25-23 02:30PM	Late-Breaking Data Show Esprit BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care (PR Newswire)
12:00PM	Can Health Tech Be the Most Helpful Technology of All? (ACCESSWIRE)
11:42AM	Teladoc Health (TDOC) Q3 Loss Narrows on Integrated Care Strength (Zacks)
08:28AM	5 Stocks to Watch on Solid Revenues in Last Reported Quarter (Zacks)
04:15AM	10 Best Dialysis and Kidney Disease Stocks to Buy (Insider Monkey)
Oct-24-23 06:18PM	Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves (PR Newswire)
12:11PM	HCA Healthcare's (HCA) Q3 Earnings Miss on High Expense Level (Zacks)
12:00PM	Sharing the Access Code to Help Open Up Diabetes Care (ACCESSWIRE)
10:01AM	Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S. (Motley Fool)
09:15AM	Shockwave Medical (SWAV) Announces IVL Studies' Positive Results (Zacks)
08:01AM	Abbott Laboratories: An Exploration into Its Intrinsic Value (GuruFocus.com)
Oct-23-23 09:00AM	Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock (Zacks)
Oct-20-23 07:31PM	Analyst Report: Abbott Laboratories (Morningstar Research)
Oct-19-23 11:56AM	Abbott Earnings Show How Obesity Drug Worries Are Overblown (Barrons.com)
09:36AM	Abbott Laboratories (NYSE:ABT) Q3 2023 Earnings Call Transcript (Insider Monkey)
09:15AM	Abbott Recognized on Fortune Change the World List (ACCESSWIRE)
08:40AM	Company News for Oct 19, 2023 (Zacks)
12:22AM	Q3 2023 Abbott Laboratories Earnings Call (Thomson Reuters StreetEvents)
Oct-18-23 05:30PM	Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript (Motley Fool)
04:35PM	Spirit AeroSystems, Abbott Labs earnings: Trending Stocks (Yahoo Finance Video)
04:09PM	Abbott Shrugs Off 'Tizzy' Over Weight-Loss Drugs, Surging On Beat And Raise (Investor's Business Daily)
03:10PM	Analyst Report: Abbott Laboratories (Morningstar Research)
02:07PM	Weight-Loss Drugs Wont Deplete Medical-Device Industry, Abbott Labs CEO Says (The Wall Street Journal)
02:07PM	Weight-Loss Drugs Like Ozempic Wont Deplete Medical-Device Industry, Abbott Labs CEO Says (The Wall Street Journal)
01:15PM	Abbott Laboratories (ABT) Q3 2023 Earnings: Strong Performance Despite COVID-19 Testing Sales ... (GuruFocus.com)
11:33AM	Abbott Laboratories (ABT): A Modestly Undervalued Gem in the Medical Devices Industry? (GuruFocus.com)
10:55AM	Geopolitical Conflicts in Middle-East in Focus (Zacks)
10:50AM	Abbott (ABT) Q3 Earnings and Revenues Surpass, Margins Dip (Zacks)
10:39AM	Pre-Markets in Red on Mid-East Concerns, Q3 Earnings in Focus (Zacks)
10:38AM	Abbott Labs, Arm, Viking Therapeutics: Top Stocks (Yahoo Finance Video)
09:50AM	Abbott Stock Is Rising. Earnings Beat and Guidance Was Strong. (Barrons.com)
09:30AM	Abbott (ABT) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
STARKS DANIEL J	Director	Oct 26	Sale	94.05	50,000	4,702,526	6,725,316	Oct 30 04:58 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Aug 08	Option Exercise	38.40	5,000	192,000	75,427	Aug 10 06:31 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Aug 08	Sale	105.03	10,400	1,092,297	65,027	Aug 10 06:31 PM
STARKS DANIEL J	Director	Jul 27	Sale	113.76	50,000	5,688,189	6,775,316	Jul 28 05:10 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	May 02	Option Exercise	47.00	8,226	386,622	78,653	May 03 07:09 PM
STARKS DANIEL J	Director	May 02	Sale	111.02	50,000	5,551,193	6,825,316	May 02 08:04 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	May 02	Sale	110.56	8,226	909,472	70,427	May 03 07:09 PM
MANNING JOSEPH J	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	1,339	134,837	62,323	Mar 02 07:40 PM
Ahlberg Gregory A	SENIOR VICE PRESIDENT	Mar 01	Sale	100.70	1,317	132,622	38,420	Mar 02 07:13 PM
Funck, Jr. Robert E.	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	1,264	127,285	218,237	Mar 02 07:35 PM
DALE MICHAEL D	SENIOR VICE PRESIDENT	Mar 01	Sale	100.70	1,209	121,746	45,133	Mar 02 07:25 PM
Watkin Jared	SENIOR VICE PRESIDENT	Mar 01	Sale	100.70	1,198	120,639	71,366	Mar 02 07:59 PM
Salvadori Daniel Gesua Sive	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	1,085	109,260	119,861	Mar 02 07:52 PM
ALLEN HUBERT L	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	1,069	107,648	175,959	Mar 02 07:16 PM
WOODGRIFT RANDEL WILLIAM	SENIOR VICE PRESIDENT	Mar 01	Sale	100.70	1,032	103,922	52,203	Mar 02 08:04 PM
Ginascol John F	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	943	94,960	118,380	Mar 02 07:36 PM
Earnhardt Lisa D	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	943	94,960	75,437	Mar 02 07:27 PM
Moreland Mary K	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.77	717	72,252	87,224	Mar 02 07:45 PM
Wainer Andrea F	EXECUTIVE VICE PRESIDENT	Mar 01	Sale	100.70	679	68,375	70,427	Mar 02 07:57 PM
Tyler Julie L.	SENIOR VICE PRESIDENT	Mar 01	Sale	100.70	525	52,868	39,162	Mar 02 07:55 PM
Tyler Julie L.	SENIOR VICE PRESIDENT	Feb 22	Sale	103.24	260	26,842	40,896	Feb 22 07:20 PM
Karam Sammy	SENIOR VICE PRESIDENT	Dec 29	Sale	108.75	4,200	456,750	26,462	Jan 03 05:32 PM
Ginascol John F	EXECUTIVE VICE PRESIDENT	Dec 13	Sale	112.32	11,000	1,235,520	111,912	Dec 15 05:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABT

Abbott Laboratories

Upgrade your FINVIZ experience